Explore by Agency

Food and Drug Administration

The gatekeeper for whether new drugs, devices, and treatments reach patients.

What
FDA
does

FDA decides which drugs, devices, and treatments are safe and effective enough to reach patients. Unlike other agencies, it mostly relies on evidence generated by others.

Where the structure falls short

FDA has no clear public standard for when real-world data is strong enough to rely on, its approval and post-market safety systems run on separate tracks, and clinical trials often don't reflect the patients who will actually use a product.

What the Blueprint recommends

Set clear rules for real-world evidence
Leadership can act

Publish clear public rules for when real-world evidence can support specific types of FDA decisions.

Connect approval to post-market safety
Can Start Now

Connect approval decisions to post-market monitoring, so the uncertainties accepted at approval get tracked and resolved.

Make trials reflect real patients
Can Start Now
Requires Congress

Make sure clinical trials enroll the people who will actually use the product. When they don't, the approval and the label must say so."

Each recommendation is tagged to show who has the authority to act and what is required to make the change:

  • Can Start Now: Officials can begin this today using authority they already have. No new decision from agency leadership is required.
  • Leadership Can Act: Agency or department leadership must make a decision, but they can do so using authority the department already has. No new law is required.
  • Requires Congress: Congressional action is required. The change cannot happen without new legislation.